Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin + Doxycycline for Rocky Mountain Spotted Fever
NCT05398055Phase 3Recruiting
- Sponsor
- Hospital General de Mexicali
- Start
- May 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of azithromycin in Rocky Mountain spotted fever (RMSF), sponsored by Hospital General de Mexicali. Started May 2022; status: recruiting.
02
Drugs
azithromycin
03
Conditions
Rocky Mountain spotted fever (RMSF)
Beyond the preview
Go deeper on NCT05398055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05398055.